Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Data: Axios research; Graphic: Andrew Witherspoon/Axios

Serbia joined Argentina, Belarus and Russia this week to be among the first countries to approve and administer Russia's Sputnik V vaccine.

The big picture: Russia has blazed its own course in the vaccine race, relying entirely on a single, state-funded vaccine that was given emergency authorization before much data was available about its effectiveness.

  • The vaccine's developers say it has a 91% efficacy rate, though that's yet to be confirmed by a medical journal or international regulator.

Now, Russia is seeking to vaccinate its population while also exporting doses around the world. The government says 1 million Russians have been vaccinated, but it has fallen far behind the number of doses it promised to deliver to cities and regions by now, per the WSJ.

  • German Chancellor Angela Merkel told Vladimir Putin on Wednesday that she is open to manufacturing doses of the vaccine in Germany, if it's approved by EU health regulators.
  • But a Hungarian government spokesman said last week that Hungary was no longer planning to rely on the Sputnik vaccine due to Russia's "inadequate manufacturing capacity" — instead focusing on vaccines provided by the EU and sourced from another world power: China.

The state of play: Health regulators in China recently approved the country's first homegrown vaccine, developed by the state-owned pharmaceutical company Sinopharm, for general use.

  • The UAE, Bahrain, Pakistan and Morocco are among those slated to receive Sinopharm doses, while Turkey, Indonesia and Brazil have preordered a vaccine developed by another Chinese company called Sinovac Biotech.
  • Regulators in Brazil announced Thursday that the Sinovac vaccine is 78% effective. Sinopharm says its vaccine is 79% effective, based on preliminary data.

What to watch: If China's vaccines prove effective — and the country can manufacture sufficient quantities to cover domestic needs and significant exports to the developing world — that could markedly improve the outlook for global vaccination in the coming years. It could also offer China a significant soft power boost.

  • Part of the reason that so many countries are lining up for doses of the Pfizer and Moderna vaccines is that the more expensive Pfizer and Moderna vaccines are bound almost exclusively for the rich world.

Go deeper:

Go deeper

Coronavirus has inflamed global inequality

Illustration: Aïda Amer/Axios

History will likely remember the pandemic as the "first time since records began that inequality rose in virtually every country on earth at the same time." That's the verdict from Oxfam's inequality report covering the year 2020 — a terrible year that hit the poorest, hardest across the planet.

Why it matters: The world's poorest were already in a race against time, facing down an existential risk in the form of global climate change. The coronavirus pandemic could set global poverty reduction back as much as a full decade, according to the World Bank.

Updated 14 hours ago - World

Portugal president wins second term, but far-right gains as COVID cases spike

President Marcelo Rebelo de Sousa at a polling station in Celorico de Basto, Portugal, on Sunday. The election took place with strict social distancing rules and other coronavirus precuatins in effect. Photo: Octavio Passos/Getty Images

Portugal's center-right President Marcelo Rebelo de Sousa said after being re-elected with 61% of the vote for a second term Sunday his priority will be to "combat the pandemic," per Reuters.

Why it matters: Portugal is currently on lockdown with the highest seven-day COVID-19 average per 100,000 and some of the highest death rates in the world, according to Johns Hopkins.